I) (cerotto transdermico): rivastigminum 25.92 mg, E 307, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, butylis methacrylatis et methylis methacrylatis polymerisatum, polyisobutylenum, polybutylenum, materiale di supporto: poly(ethylenis terephthalas), polyethylenum, tinta: blu, ad praeparationem pro 10.8 cm², cum liberatione 4.6 mg/24h.
II) (cerotto di copertura): acrylates et vinylis acetatis polymerisatum, materiale di supporto: polyesterum, ad praeparationem pro 25.1 cm².
Packungsbestandteile
I
cerotto transdermico
Active Agent
Dose
(Cerotto Transdermico): Rivastigminum
25.92 mg
Inactive agents
Dose
additional_information
2-ethylhexylis Acrylatis
Ad Praeparationem
10.8 cm
Blu
tinta
Butylis Methacrylatis
Cum Liberatione
4.6mg / 24h
E 307
Methylis Methacrylatis Polymerisatum
Poly(Ethylenis Terephthalas)
materiale di supporto
Polybutylenum
Polyethylen
Polyisobutylenum
Vinylis Acetatis Polymerisatum
II
cerotto transdermico
Inactive agents
Dose
additional_information
(Cerotto di Copertura): Acrylates
Ad Praeparationem
25.1 cm
Polyesterum
materiale di supporto
Vinylis Acetatis Polymerisatum
Source
Data was imported : 07.01.2026
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
